I know many of us have talked about the potential for the new HIV vaccine (NOT to be confused with the HVTN 505), but I wanted to share the actual journal article that published the findings initially. It was the cover of this week’s issue of Science. There is some heavy information packed in there but what I appreciated most was the interaction between the fields of immunology, biochemistry, genetics, and nanoparticle chemistry that took in developing this immunagen that engages B cell receptors and results in an antibody response. The innovation has the potential to revolutionize not only vaccine methods targeting HIV but also other diseases where highly variable viruses are involved. Furthermore, it shows how the lines between the traditional established “fields” and “disciplines” are fading and how research is becoming more and more interdisciplinary.
- New vaccine-design approach targets viruses such as HIV (sciencedaily.com)